Neuropeptide trefoil factor 3 attenuates naloxone-precipitated withdrawal in morphine-dependent mice

Psychopharmacology

Volumn 231, Issue 24, 2014, Pages 4659-4668

  Wu, Ping ^a   Shi, Hai Shui ^c   Luo, Yi Xiao ^a   Zhang, Ruo Xi ^a   Li, Jia Li ^a   Shi, Jie ^a   Lu, Lin ^a,b   Zhu, Wei Li ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Addiction; c fos; Corticosterone; Fos; Morphine; Trefoil factor 3; Withdrawal

Indexed keywords

MORPHINE; NALOXONE; NARCOTIC AGENT; PEPTIDE; PROTEIN C FOS; TREFOIL FACTOR;

ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; MALE; METABOLISM; MOUSE; OPIOID-RELATED DISORDERS; PHYSIOLOGY; PREFRONTAL CORTEX; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; MALE; MICE; MORPHINE; NALOXONE; NARCOTICS; OPIOID-RELATED DISORDERS; PEPTIDES; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84922830540     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3615-1     Document Type: Article

References (59)

1. Antonijevic IA, Russell JA, Bicknell RJ, Leng G, Douglas AJ (2000) Effect of progesterone on the activation of neurones of the supraoptic nucleus during parturition. J Reprod Fertil 120:367-376
2. Baumeister AA, Richard AL, Richmond-Landeche L, Hurry MJ, Waguespack AM (1992) Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome. Neuropharmacology 31:835-841
3. Baus-Loncar M, Giraud AS (2005) Multiple regulatory pathways for trefoil factor (TFF) genes. Cell Mol Life Sci 62:2921-2931
4. Bickel WK, Stitzer ML, Liebson IA, Bigelow GE (1988) Acute physical dependence in man: effects of naloxone after brief morphine exposure. J Pharmacol Exp Ther 244:126-132
5. Chen L, Zhai H, Lu L, Chen S, Ning Y, Wang W (2011) Effects of polyinosinic-polycytidylic acid (Poly I:C) on naloxone-precipitated withdrawal in morphine-dependent mice. Neurosci Lett 487:341-344
6. Chiang HC, Wang L, Xie Z, Yau A, Zhong Y (2010) PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila. Proc Natl Acad Sci U S A 107:7060-7065
7. Covington HE 3rd, Lobo MK, Maze I, Vialou V, Hyman JM, Zaman S, LaPlant Q, Mouzon E, Ghose S, Tamminga CA, Neve RL, Deisseroth K, Nestler EJ (2010) Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci 30:16082-16090
8. Diaz SL, Kemmling AK, Rubio MC, Balerio GN (2001) Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice. Behav Pharmacol 12:75-79
9. Dong J, Yin H, Liu W, Wang P, Jiang Y, Chen J (2005) Congenital iodine deficiency and hypothyroidism impair LTP and decrease C-fos and C-jun expression in rat hippocampus. Neurotoxicology 26:417-426
10. Erb S, Shaham Y, Stewart J (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berlin) 128:408-412
11. Farzin D (1999) Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice. Eur J Pharmacol 377:35-42
12. Feany MB (1996) Neuropeptide modulation of learning and memory processes. Rev Neurosci 7:151-164
13. Gong YX, Zhang WP, Shou WT, Zhong K, Chen Z (2010) Morphine induces conditioned place preference behavior in histidine decarboxylase knockout mice. Neurosci Lett 468:115-119
14. Gracy KN, Dankiewicz LA, Koob GF (2001) Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24:152-160
15. Griepentrog T, Bauer M, Hornstein C, Sauer H, Jirikowski GF (2000) Coexistence of intestinal trefoil factor (hITF) and oxytocin in magnocellular neurons in the human hypothalamus. Horm Metab Res 32:121-124
16. Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA (1989) Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I. J Pharmacol Exp Ther 250:485-491
17. Huston JP, Hasenohrl RU (1995) The role of neuropeptides in learning: focus on the neurokinin substance P. Behav Brain Res 66:117-127
18. Jiang WG, Li SX, Zhou SJ, Sun Y, Shi J, Lu L (2011) Chronic unpredictable stress induces a reversible change of PER2 rhythm in the suprachiasmatic nucleus. Brain Res 1399:25-32
19. Jiang WG, Li SX, Liu JF, Sun Y, Zhou SJ, Zhu WL, Shi J, Lu L (2013) Hippocampal CLOCK protein participates in the persistence of depressive-like behavior induced by chronic unpredictable stress. Psychopharmacology (Berlin) 227:79-92
20. Kalinichev M, Holtzman SG (2003) Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence. J Pharmacol Exp Ther 304:603-609
21. Kaplan GB, Leite-Morris KA, Joshi M, Shoeb MH, Carey RJ (2003) Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res 987:122-125
22. Kirsz K, Zieba DA (2011) Ghrelin-mediated appetite regulation in the central nervous system. Peptides 32:2256-2264
23. Kjellev S, Vestergaard EM, Nexo E, Thygesen P, Eghoj MS, Jeppesen PB, Thim L, Pedersen NB, Poulsen SS (2007) Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contents. Peptides 28:1197-1206
24. Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS (2010) Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A 107:2669-2674
25. Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191
26. Kovacs KJ (1998) c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem Int 33:287-297
27. Landgraf R (2005) Neuropeptides in anxiety modulation. Handb Exp Pharmacol 335-369
28. Laorden ML, Fuertes G, Gonzalez-Cuello A, Milanes MV (2000) Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors. J Pharmacol Exp Ther 293:578-584
29. Laorden ML, Nunez C, Almela P, Milanes MV (2002) Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones. J Neurochem 83:132-140
30. Leggio L, Addolorato G, Cippitelli A, Jerlhag E, Kampov-Polevoy AB, Swift RM (2011) Role of feeding-related pathways in alcohol dependence: a focus on sweet preference, NPY, and ghrelin. Alcohol Clin Exp Res 35:194-202
31. Li M, Hou YY, Lu B, Chen J, Chi ZQ, Liu JG (2009) Expression pattern of neural synaptic plasticity marker-Arc in different brain regions induced by conditioned drug withdrawal from acute morphine-dependent rats. Acta Pharmacol Sin 30:282-290
32. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959-964
33. Logrip ML, Koob GF, Zorrilla EP (2011) Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs 25:271-287
34. Lu L, Huang M, Liu Z, Ma L (2000a) Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats. Neuroreport 11:829-832
35. Lu L, Liu D, Ceng X, Ma L (2000b) Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur J Neurosci 12:4398-4404
36. Lu L, Zeng S, Liu D, Ceng X (2000c) Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci Lett 291:191-195
37. Lu L, Chen H, Su W, Ge X, Yue W, Su F, Ma L (2005) Role of withdrawal in reinstatement of morphine-conditioned place preference. Psychopharmacology (Berlin) 181:90-100
38. Maldonado R, Stinus L, Gold LH, Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677
39. Mannelli P, Gottheil E, Peoples JF, Oropeza VC, Van Bockstaele EJ (2004) Chronic very low dose naltrexone administration attenuates opioid withdrawal expression. Biol Psychiatry 56:261-268
40. Merighi A, Salio C, Ferrini F, Lossi L (2011) Neuromodulatory function of neuropeptides in the normal CNS. J Chem Neuroanat 42:276-287
41. Mesripour A, Hajhashemi V, Rabbani M (2008) Metyrapone and mifepristone reverse recognition memory loss induced by spontaneous morphine withdrawal in mice. Basic Clin Pharmacol Toxicol 102:377-381
42. Ogren SO, Kuteeva E, Elvander-Tottie E, Hokfelt T (2010) Neuropeptides in learning and memory processes with focus on galanin. Eur J Pharmacol 626:9-17
43. Pan W, Kastin AJ (2008) Urocortin and the brain. Prog Neurobiol 84:148-156
44. Panchal V, Taraschenko OD, Maisonneuve IM, Glick SD (2005) Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine. Eur J Pharmacol 525:98-104
45. Picciotto MR (2010) Galanin and addiction. EXS 102:195-208
46. Portelli J, Michotte Y, Smolders I (2012) Ghrelin - an emerging new anticonvulsant neuropeptide. Epilepsia 53:585-595
47. Ramin M, Azizi P, Motamedi F, Haghparast A, Khodagholi F (2010) Inhibition of JNK phosphorylation reverses memory deficit induced by beta-amyloid (1-42) associated with decrease of apoptotic factors. Behav Brain Res 217:424-431
48. Rotzinger S, Lovejoy DA, Tan LA (2010) Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31:736-756
49. Shi HS, Yin X, Song L, Guo QJ, Luo XH (2012a) Neuropeptide Trefoil factor 3 improves learning and retention of novel object recognition memory in mice. Behav Brain Res 227:265-269
50. Shi HS, Zhu WL, Liu JF, Luo YX, Si JJ, Wang SJ, Xue YX, Ding ZB, Shi J, Lu L (2012b) PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3. Neuropsychopharmacology 37:2671-2683
51. Siegel RK, Gusewelle BE, Jarvik ME (1975) Naloxone-induced jumping in morphine dependent mice: stimulus control and motivation. Int Pharmacopsychiatry 10:17-23
52. Steketee JD (2005) Cortical mechanisms of cocaine sensitization. Crit Rev Neurobiol 17:69-86
53. Sundquist SJ, Nisenbaum LK (2005) Fast Fos: rapid protocols for single- and double-labeling c-Fos immunohistochemistry in fresh frozen brain sections. J Neurosci Methods 141:9-20
54. Tang YL, Zhao D, Zhao C, Cubells JF (2006) Opiate addiction in China: current situation and treatments. Addiction 101:657-665
55. Ueno K, Maeda T, Kiguchi N, Kobayashi Y, Ozaki M, Kishioka S (2011) Availability of serum corticosterone level for quantitative evaluation of morphine withdrawal in mice. Drug Discov Ther 5:71-75
56. Wang X, Cen X, Lu L (2001) Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol 432:153-161
57. Wang J, Fang Q, Liu Z, Lu L (2006) Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berlin) 185:19-28
58. Zarrindast MR, Farzin D (1996) Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice. Eur J Pharmacol 298:1-6
59. Zhang J, Yao Y, Xiao F, Lan X, Yu C, Zhang Y, Jiang C, Yang J, Pei G, Li Y, Rong S, Hu S, Li J, Xu G (2013) Administration of dexamethasone protects mice against ischemia/reperfusion induced renal injury by suppressing PI3K/AKT signaling. Int J Clin Exp Pathol 6:2366-2375